Inivata is a leader in liquid biopsy. Its InVision® platform unlocks essential genomic information from a simple blood test to transform the care of cancer patients. The Company’s technology is based on pioneering research from the Cancer Research UK Cambridge Institute, University of Cambridge and backed by multiple high calibre publications. Its lead product, InVisionFirst™-Lung, is commercially available and provides molecular insights that enable clinicians to make more informed treatment decisions for NSCLC patients. Inivata is partnering with pharmaceutical and biotechnology companies on InVisionFirst-Lung and its wider platform, which is applicable to a range of cancer types. The Company has a CLIA laboratory in Research Triangle Park, NC and R&D laboratories in Cambridge, UK. For more information, please go to www.inivata.com. Follow us on Twitter @Inivata. For more information, please go to www.inivata.com. Follow us on Twitter @Inivata.
Looking for a particular Inivata employee's phone or email?
Inivata Questions
The Inivata annual revenue was $16.9 million in 2026.
Hani Yakan is the Director of Inivata.
30 people are employed at Inivata.
Inivata is based in Durham, North Carolina.
The NAICS codes for Inivata are [5417, 54, 541714, 54171, 541].
The SIC codes for Inivata are [873, 8731, 87, 73].
Top Inivata Employees
-
Hani Yakan
Director at Inivata
Florida, United States25 -
3
-
Robert Ventura
Bioinformatics Analyst at Inivata
New York, United States21 -
Sweta Singh
Associate Laboratory Director at Inivata
United States1
Related Companies
